Smoking Cessation Treatment for Head and Neck Cancer Patients

Conditions

Smoking Cessation

What is the purpose of this trial?

This is a pilot research study examining the use of varenicline (Chantix) and the nicotine patch. The study is designed to find out whether one of these medications is more effective for smoking cessation with head and neck cancer patients. The study has three parts: 1) two intake sessions; 2) an 8-week treatment phase, and 3) a 3-month follow-up.



Participation Guidelines

Age:
18 Years - N/A
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Yale University
Dates:
July 2009
Last Updated:
July 12, 2013
Study HIC#:

Clinicaltrials.gov ID: NCT00931021